Aim: To evaluate success rate (efficacy, safety) in treatment of post-chemical injuries and corneal defects using autologous serum eye drops. Material and Methods: Authors reviewed 93 patients (116 eyes) hospitalized in Clinic of ophthalmology from 2010 to 2013, who had post-causoma corneal defects that were nonresponsive to conventional treatment and were treated with serum therapy. Authors correlated time of epithelialization of defects with rate of epithelial healing. Results: Authors investigated 93 patients (52 males, 41 females; aged 18 - 74) for treatment of corneal defects. Application of autologous serum therapy 56 (48.28%) of 116 eyes was healed in an average time of 4 weeks. Among 116 eyes, epithelial defects healed in 4 (3.45%) ...
AIM: To evaluate the role of umbilical cord blood serum (CBS) therapy in cases with persistent corne...
BackgroundThe aim of the study is to test whether use of autologous serum eye-drops can provide earl...
Joanna von Hofsten,1,2 Maria Egardt,2 Madeleine Zetterberg2–41Department of Ophthalmology, Hal...
Aim: To evaluate success rate (efficacy, safety) in treatment of post-chemical injuries and corneal ...
Aim: To evaluate success rate (efficacy, safety) in treatment of post-chemical injuries and corneal ...
2021 / Accepted: 01-08-2021AbstractBackground: Ocular chemical injuries are true ophthalmic emergenc...
Purpose. This study evaluated the efficacy of 50% autologous serum eye drops in ocular surface disea...
Purpose. This study evaluated the efficacy of 50% autologous serum eye drops in ocular surface disea...
Copyright © 2013 Kaevalin Lekhanont et al. This is an open access article distributed under the Crea...
The purpose of this study was to investigate the efficacy and safety of topical 100% serum eye drops...
Copyright © 2014 Francesco Semeraro et al. This is an open access article distributed under the Crea...
AIM: To study the effect of autologous serum in corneal epithelial healing after photorefractive ker...
<h2>Background: The aim of the present study was to evaluate the efficacy of autologous serum eye dr...
Pur po se: To evaluate the effect of autologous serum application on epithelization in the treatment...
AIM: To investigate the efficacy of autologous serum combined with recombinant human epidermal growt...
AIM: To evaluate the role of umbilical cord blood serum (CBS) therapy in cases with persistent corne...
BackgroundThe aim of the study is to test whether use of autologous serum eye-drops can provide earl...
Joanna von Hofsten,1,2 Maria Egardt,2 Madeleine Zetterberg2–41Department of Ophthalmology, Hal...
Aim: To evaluate success rate (efficacy, safety) in treatment of post-chemical injuries and corneal ...
Aim: To evaluate success rate (efficacy, safety) in treatment of post-chemical injuries and corneal ...
2021 / Accepted: 01-08-2021AbstractBackground: Ocular chemical injuries are true ophthalmic emergenc...
Purpose. This study evaluated the efficacy of 50% autologous serum eye drops in ocular surface disea...
Purpose. This study evaluated the efficacy of 50% autologous serum eye drops in ocular surface disea...
Copyright © 2013 Kaevalin Lekhanont et al. This is an open access article distributed under the Crea...
The purpose of this study was to investigate the efficacy and safety of topical 100% serum eye drops...
Copyright © 2014 Francesco Semeraro et al. This is an open access article distributed under the Crea...
AIM: To study the effect of autologous serum in corneal epithelial healing after photorefractive ker...
<h2>Background: The aim of the present study was to evaluate the efficacy of autologous serum eye dr...
Pur po se: To evaluate the effect of autologous serum application on epithelization in the treatment...
AIM: To investigate the efficacy of autologous serum combined with recombinant human epidermal growt...
AIM: To evaluate the role of umbilical cord blood serum (CBS) therapy in cases with persistent corne...
BackgroundThe aim of the study is to test whether use of autologous serum eye-drops can provide earl...
Joanna von Hofsten,1,2 Maria Egardt,2 Madeleine Zetterberg2–41Department of Ophthalmology, Hal...